Medication
Prevalence N (%)
Median [IQR] Dose (% target)
Dose (% target) Average ± SD
Patients receiving > 50% target dose
BB 155 (83.3%) 25 [12.5;50] 32 ± 25% 18/155 (11.6%)
AngA 162 (87.1%) 25 [12.5;50] 38.2 ± 30% 34/162 (21%)
MRA 110 (59.1%) 25 [0;50] 31 ± 30% 16/110 (14.5%)